R3470-3471-3479 (REGN-EB3) Expanded Access Protocol (EAP) for Treatment of Ebola Virus Disease
Clinical trial NCT03576690 · AVAILABLE
Trial details
- NCT number
- NCT03576690
- Sponsor
- Regeneron Pharmaceuticals
- Status
- AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.